China688607.CG▼
Kangzhong Medical's first-half net loss widens to 23.71 million yuan
Kangzhong Medical released its 2026 interim report on August 27. First-half operating revenue was 144 million yuan, down 0.7 percent year on year. Net profit attributable to the parent swung from a loss of 740,000 yuan in the same period last year to a loss of 23.71 million yuan. Net profit attributable to the parent after deducting non-recurring items widened from a loss of 3.39 million yuan to a loss of 28.35 million yuan. Net operating cash flow was negative 17.47 million yuan, an improvement of 64.6 percent year on year. Earnings per share were negative 0.269 yuan. In the second quarter, operating revenue was 75.28 million yuan, down 12.9 percent year on year. Net profit attributable to the parent was a loss of 7.5 million yuan, down 395.2 percent year on year. Net profit attributable to the parent after deducting non-recurring items was a loss of 11.97 million yuan, down 1,022.1 percent year on year. As of the end of the second quarter, total assets were 1.478 billion yuan, up 51.2 percent from the end of the previous year. Net assets attributable to the parent were 838 million yuan, down 1.9 percent from the end of the previous year. The company said that in the first half, production and sales of its main product, digital X-ray flat panel detectors, remained stable. At the same time, through the acquisition of Maide Intelligent Technology, it expanded into the field of ultrasound image-assisted diagnosis. Demand for new products in the pet medical and industrial inspection fields increased.